PTC Therapeutics
PTCT
#2836
Rank
NZ$10.07 B
Marketcap
NZ$121.69
Share price
-0.34%
Change (1 day)
72.49%
Change (1 year)

PTC Therapeutics (PTCT) - Total debt

Total debt on the balance sheet as of December 2025 : NZ$4.63 Billion

According to PTC Therapeutics 's latest financial reports the company's total debt is NZ$4.63 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

PTC Therapeutics - Total debt on balance sheet (from 2012 to 2025)

Total debt by year

Year Total debt Change
2025-12-31NZ$4.67 B6.68%
2024-12-31NZ$4.38 B24.3%
2023-12-31NZ$3.52 B53.12%
2022-12-31NZ$2.30 B23.87%
2021-12-31NZ$1.85 B218.93%
2020-12-31NZ$0.58 B19.63%
2019-12-31NZ$0.48 B113.52%
2018-12-31NZ$0.22 B11.75%
2017-12-31NZ$0.20 B43.96%
2016-12-31NZ$0.14 B5.66%
2015-12-31NZ$0.13 B
2014-12-31N/A-100%
2013-12-31NZ$0.05 M-99%
2012-12-31NZ$5.93 M-60.37%
2011-12-31NZ$14.97 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
NZ$60.61 B 1,206.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$3.47 B-24.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.32 B-93.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$1.78 B-61.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.13 B-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$84.39 M-98.18%๐Ÿ‡บ๐Ÿ‡ธ USA